Literature DB >> 11042670

The TRAIL DISCussion: It is FADD and caspase-8!

M E Peter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11042670     DOI： 10.1038/sj.cdd.4400735

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  11 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.

Authors:  Guillaume Jacquemin; Virginie Granci; Anne Sophie Gallouet; Najoua Lalaoui; Aymeric Morlé; Elisabetta Iessi; Alexandre Morizot; Carmen Garrido; Thierry Guillaudeux; Olivier Micheau
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

3.  Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.

Authors:  Terri B Hunter; Neil J Manimala; Kimberly A Luddy; Tracy Catlin; Scott J Antonia
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

Review 4.  Following the TRAIL to apoptosis.

Authors:  Bharti R Chaudhari; Richard F Murphy; Devendra K Agrawal
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Autophagy as a mechanism of Apo2L/TRAIL resistance.

Authors:  Arishya Sharma; Alexandru Almasan
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

Review 6.  Roles of RIPK3 in necroptosis, cell signaling, and disease.

Authors:  Michael J Morgan; You-Sun Kim
Journal:  Exp Mol Med       Date:  2022-10-12       Impact factor: 12.153

7.  Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma.

Authors:  Xiao-Ping Chen; Song-Qing He; Hai-Ping Wang; Yong-Zhong Zhao; Wan-Guang Zhang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

8.  Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells.

Authors:  Edwin Bremer; Douwe Samplonius; Bart-Jan Kroesen; Linda van Genne; Lou de Leij; Wijnand Helfrich
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

9.  Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

Authors:  E W Duiker; A Meijer; A R M van der Bilt; G J Meersma; N Kooi; A G J van der Zee; E G de Vries; S de Jong
Journal:  Br J Cancer       Date:  2011-04-12       Impact factor: 7.640

Review 10.  Onto better TRAILs for cancer treatment.

Authors:  D de Miguel; J Lemke; A Anel; H Walczak; L Martinez-Lostao
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.